Ameritas Life Insurance Corp. Indexed Universal Life Insurance With Flexible Premium Options Fit Review

Research Snapshot

Why Ameritas Life Insurance Corp. Qualified for This Study

Questions This Section Answers

• Is Ameritas Life Insurance Corp. a good choice for Indexed Universal Life Insurance With Flexible Premium Options?
• Why did only two of five AI platforms name Ameritas Life Insurance Corp. in the ranking stage?

Ameritas qualified because it sells a named indexed universal life product that matches the buyer's stated goal of permanent coverage with adjustable premium funding. Ameritas identifies Growth II Index Universal Life as an indexed universal life product and discusses IUL applications ^[4]. Ameritas also describes Growth IUL II as an accumulation-focused IUL ^[5].

The carrier cleared the study's minimum-mention threshold of two platforms. DeepSeek listed Ameritas at rank 8 and Kimi at rank 7, producing an average listed rank of 7.5 and a best listed rank of 7. Three other platforms that evaluated fit — OpenAI, Perplexity, and Grok — did not name Ameritas during ranking discovery, so its 40% platform share reflects ranking-stage visibility only, not the total number of platforms that assessed it.

Financial strength supported inclusion. Ameritas reports an A+ financial-strength rating from S&P Global Ratings and an A rating from AM Best in 2026 materials ^[6], and AM Best independently affirmed an A (Excellent) rating with a stable outlook effective June 4, 2026 ^[7]. S&P Global Ratings reported an A+ stable rating for Ameritas life insurance Corp. dated April 8, 2026 ^[8]. These ratings are opinions of insurer claims-paying ability, not guarantees of policy performance, cash value, or investment return ^[6].

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance With Flexible Premium Options

Questions This Section Answers

• Which Ameritas Life Insurance Corp. product should a buyer choose for Indexed Universal Life Insurance With Flexible Premium Options?
• Is Ameritas Growth IUL II currently issued, and what flexible premium terms does it include?

The most relevant product is Ameritas Growth IUL II, an accumulation-focused indexed universal life policy issued by Ameritas Life Insurance Corp. ^[9]. Ameritas says Growth Index Universal Life II is issued in approved states and is not available in New York ^[11].

Flexible premium mechanics are the core of the fit case, and the evidence here is split by source type. Third-party product guides state that policyowners can make unscheduled premium payments at any time until age 121 and that planned periodic premiums are adjustable with written notice ^[12]. The same guides describe a 0% floor and a 4% lookback guarantee over the first 10 years on Growth IUL II ^[13]. Ameritas's own universal life description says universal life policies typically allow premium adjustment, coverage changes, and skipping premiums if enough cash value exists ^[15].

Company-owned materials do not confirm the same level of detail. The public product page is directed primarily to industry professionals and does not disclose a complete consumer contract, charge schedule, or state-specific illustration ^[9]. DeepSeek could not confirm whether Growth IUL II is currently issued or verify its exact flexible-premium terms from the sources it reviewed ^[16]. Kimi likewise found that specific premium adjustment mechanics, minimum premium floors, and flexibility boundaries are not fully disclosed in publicly available documents ^[17].

Public materials also use different product names across years and states, creating uncertainty about the exact current form and included riders ^[11]. Buyers should confirm the exact policy form number and state approval status before relying on any product name.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree about Ameritas Life Insurance Corp. for Indexed Universal Life Insurance With Flexible Premium Options?
• Does Ameritas Life Insurance Corp. offer permanent coverage with cash-value potential for flexible-premium IUL buyers?

Platforms agreed on three points.

First, the product category matches the use case. Ameritas markets indexed universal life insurance, and the reviewed platforms consistently identified Growth IUL II or Ameritas Indexed Universal Life as the relevant offering ^[19]. Ameritas describes IUL as lifelong death-benefit coverage with a cash-value component accessible through policy loans or withdrawals ^[22].

Second, flexible premium funding is a standard universal life feature rather than a differentiated Ameritas strength. Ameritas states that universal life policies typically offer flexible premium payments, coverage adjustments, and the ability to skip premiums if enough cash value exists ^[23]. DeepSeek made the same point, noting that IUL premium flexibility is a common industry feature ^[20].

Third, premium flexibility shifts funding risk to the buyer. IUL policies require sufficient cash value to cover monthly deductions, and underfunding can lead to lapse or reduced death benefit ^[24]. The NAIC consumer guidance cited by DeepSeek emphasizes monitoring policy performance ^[24].

Platforms also agreed that financial-strength ratings are not performance guarantees. Ameritas reports A+ (S&P) and A (AM Best) ratings ^[25], and AM Best independently affirmed A (Excellent) with a stable outlook on June 4, 2026 ^[26]. Kimi separately cited an A (Excellent) AM Best rating ^[27]. These ratings describe claims-paying ability, not cash-value outcomes ^[25].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Why do AI platforms disagree about whether Ameritas Life Insurance Corp. is a strong fit for flexible-premium IUL?
• How long is the no-lapse guarantee on Ameritas Growth IUL II, and is that term verified?

Fit ratings diverged sharply. Grok rated Ameritas a strong fit ^[29]. OpenAI and Perplexity each rated it good ^[30]. DeepSeek rated it mixed ^[32]. Kimi rated it uncertain ^[33]. No platform rated it poor, and no platform rated it conclusively best.

The disagreement centers on verifiability, not product existence. Grok relied on third-party product guides that state specific terms, including a 7% premium charge (current and maximum), a $7 monthly policy fee (current), a $10 maximum monthly fee, per-$1,000 specified-amount charges, and surrender charges declining to zero in year 11 ^[34]. Grok also reported a 10-year minimum no-lapse guarantee period ^[35] and loan interest of 3.38% in years 1–10 ^[34]. These figures come from independent distributor documents, not from Ameritas's own consumer disclosures, and were not independently verified in this study.

OpenAI, DeepSeek, Kimi, and Perplexity all reported that current product-specific charges were not publicly verified. OpenAI found that exact administrative, premium, rider, loan, withdrawal, surrender, and indexed-account charges are unclear from the sources reviewed ^[36]. DeepSeek found no public pricing or charge schedule for the named product ^[32]. Kimi found that Ameritas charge structures are not publicly detailed in accessible documents, unlike competitors such as John Hancock and Protective ^[37]. Perplexity found no verifiable public quote or standardized current premium schedule ^[31].

The cap rate is a specific conflict. Ameritas publicly reported a 9.50% cap for Growth IUL II in a January 2024 company article ^[36]. That figure does not establish the current 2026 cap, participation rate, spread, index options, or credited-rate schedule ^[36]. Perplexity noted the same limitation, describing the 9.50% figure as one illustration context rather than a standardized current quote ^[39].

No-lapse protection is unresolved. OpenAI found that publicly reviewed sources did not disclose a product-specific guaranteed death-benefit schedule or no-lapse guarantee for Growth IUL II ^[30]. Grok reported a 10-year minimum no-lapse guarantee period and flagged it as shorter than some competitors ^[35]. Kimi could not independently verify no-lapse guarantee duration or conditions ^[33]. DeepSeek could not confirm whether a no-lapse guarantee exists or what its funding requirements are ^[32].

State availability is a confirmed limitation. Ameritas says Growth Index Universal Life II is not available in New York and that policy and rider availability varies by state ^[31].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does Ameritas Growth IUL II offer for a buyer who wants flexible premium payments and indexed cash-value growth?
• Does Ameritas Growth IUL II include riders, and do those riders carry extra charges?

The features most relevant to this use case are premium flexibility, indexed crediting with a floor, and optional riders. Evidence quality varies by feature.

Premium flexibility is supported by Ameritas's own universal life description, which states that universal life policies typically allow premium adjustment, coverage changes, and skipping premiums if enough cash value exists ^[40]. Third-party guides add that unscheduled payments can be made until age 121 and planned premiums are adjustable with written notice ^[41]. The exact minimum, target, maximum, planned-premium, and lapse-prevention rules were not located in the public materials reviewed ^[42].

Indexed cash-value potential rests on a 0% floor and a 4% lookback guarantee over the first 10 years, per third-party product guides ^[44]. Ameritas's own January 2024 article reported a 9.50% cap while discussing illustration assumptions, loan treatment, and in-force comparisons ^[43]. Indexed interest is not the same as direct index investment performance; caps, participation rates, spreads, charges, loans, and policy expenses can materially affect results ^[43].

Death-benefit protection is structurally present but not product-specifically documented. The product is designed as indexed universal life insurance, so it provides a life-insurance death benefit subject to the policy's contract terms, premium sufficiency, charges, and lapse provisions ^[42]. Publicly reviewed sources did not disclose a product-specific guaranteed death-benefit schedule or no-lapse guarantee for Growth IUL II ^[42].

Riders exist but their terms are incomplete. Ameritas promotional material mentions a 10-year lookback guarantee, a lifetime income rider, a Care4Life 2.0 rider, an index credit enhancement, and an early cash value rider, and notes that riders may have limitations, restrictions, and additional charges ^[46]. Grok reported that living-benefits riders such as Care4Life are included on policies ^[47]. Perplexity found that availability and terms vary and that public materials do not confirm which riders are included in the exact in-force Growth IUL II design ^[48].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Ameritas Growth IUL II cost per month, and what premium charges apply?
• What surrender charges and cancellation terms apply to Ameritas Growth IUL II?

No consumer-specific premium quote or publicly verified schedule of Growth IUL II charges was found ^[49]. Pricing confidence is low across OpenAI, DeepSeek, Perplexity, and Kimi ^[50]. Grok reported moderate pricing confidence based on third-party distributor documents ^[54].

The only specific cost figures in the evidence set come from independent distributor materials cited by Grok. Those materials state a 7% premium charge (current and maximum), a $7 monthly expense charge (current) with a $10 maximum, additional per-$1,000 specified-amount charges, and a minimum specified amount of $50,000 ^[54]. The same materials state that surrender charges decline to zero in year 11 ^[54] and that loan interest applies, for example 3.38% in years 1–10 ^[54]. These figures are platform-reported from third-party documents and were not independently verified in this study.

Other platforms describe the same cost categories without amounts. OpenAI lists premiums required to support the selected death benefit and policy design, cost of insurance and other policy charges, and potential policy-loan interest, withdrawals, rider charges, and surrender-related reductions, all subject to the contract ^[50]. DeepSeek notes that cost of insurance charges, administrative fees, and surrender charges are typical IUL components but that specific Ameritas Growth IUL II amounts were not verified ^[51]. Kimi lists partial surrender or withdrawal fees, indexed account performance charges, and rider charges as additional fees with amounts not publicly specified ^[53].

Contract terms are not publicly fixed. Public materials do not establish a fixed contract term or a guaranteed right to skip premiums without lapse risk ^[50]. Surrendering or heavily borrowing against the policy may reduce cash value and death benefit and may create tax consequences ^[50]. DeepSeek notes that IUL policies are permanent contracts and that surrender or partial withdrawal may incur charges and reduce or eliminate cash value and death benefit ^[51]. Kimi notes that full surrender would terminate coverage and may generate taxable income if cash value exceeds basis ^[53].

The 9.50% cap cited by Ameritas is not a price and should not be treated as a guaranteed return ^[50].

Best Suited For

Questions This Section Answers

• Who is Ameritas Life Insurance Corp. best suited for among flexible-premium IUL buyers?
• Is Ameritas Life Insurance Corp. a good fit for a buyer who wants permanent coverage from a financially established carrier?

Ameritas is best suited for buyers who want permanent death-benefit protection combined with indexed cash-value accumulation potential and who are willing to manage premiums and policy values over time ^[55]. Buyers who value a financially established carrier and will review a personalized illustration before committing also fit this profile ^[55].

Buyers comparing accumulation-focused IUL designs where disciplined funding and detailed policy illustrations are available are a reasonable match ^[55]. So are buyers who want multiple IUL product variants to match either accumulation or protection objectives ^[57].

Buyers who prioritize a mutual insurance company structure and an AM Best A (Excellent) rating also align with what the evidence supports ^[58]. Ameritas is an established U.S. life insurer with an indexed universal life offering relevant to a permanent-coverage goal ^[56].

Buyers who understand that premium flexibility shifts funding risk to them and who will monitor policy performance fit the product's actual mechanics ^[60].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Ameritas Life Insurance Corp. for Indexed Universal Life Insurance With Flexible Premium Options?
• Is Ameritas Growth IUL II a poor fit for buyers who need guaranteed premiums or fully transparent public pricing?

Ameritas is probably not best suited for buyers who need simple, low-cost death-benefit protection without cash-value complexity ^[61]. Buyers who require fully guaranteed premiums, guaranteed cash values, or highly transparent public pricing are also a poor match ^[61].

Buyers who need guaranteed, fully predictable premium schedules with no cash-value variability should look elsewhere ^[62]. So should buyers who require verified, publicly documented product terms before engaging a carrier or agent ^[62].

Buyers prioritizing the highest currently illustrated cap or accumulation assumptions without independently stress-testing charges and lapse risk are not well served by this product ^[61]. Buyers who need the longest no-lapse guarantees or the lowest-cost IUL options should compare other carriers ^[63].

Buyers in New York cannot buy Growth IUL II specifically, because Ameritas says the product is not available there ^[64]. Buyers who need immediate confidence in no-lapse guarantee duration and conditions without speaking to an advisor are also a poor fit given the documentation gaps ^[65].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Ameritas Life Insurance Corp. for a buyer who needs disclosed policy charges?
• When should a buyer choose term, guaranteed universal life, or fixed universal life instead of Ameritas Growth IUL II?

A different carrier may be better when it provides lower guaranteed charges, stronger contractual no-lapse protection, clearer premium-flexibility mechanics, or more favorable current and guaranteed illustrations ^[66]. Kimi identified competitors with more disclosed terms: John Hancock Protection IUL discloses a 35% premium charge in years 1–10, a 0.165% monthly indexed account charge, a $15 monthly administrative fee, and a 15-year surrender charge schedule ^[67]. Pacific Life Trident IUL offers 4–20 years of base no-lapse protection with an optional No-Lapse Guarantee Rider extending to lifetime ^[68]. Protective Indexed Choice offers competitive CVAT/GPT testing, no stated maturity age, and charges that discontinue at age 121 ^[69]. Mutual of Omaha IUL Express provides guaranteed 20-year coverage, or to age 80 if the planned premium meets the no-lapse threshold ^[70].

Term life may be better when the buyer primarily needs affordable death-benefit protection and does not need permanent cash value ^[66]. Guaranteed universal life may be better when predictable lifetime death-benefit guarantees matter more than indexed cash-value upside ^[66]. A fixed universal life policy may be better when the buyer prefers less dependence on index-crediting assumptions and simpler credited-interest mechanics ^[66].

If the buyer prioritizes guaranteed level premiums and pure death benefit, a guaranteed universal life or term policy may be more suitable ^[71]. If the buyer's primary goal is low-cost coverage, term insurance often provides more death benefit per dollar ^[71]. If the buyer wants fully published, easily compared product terms, a carrier with more transparent public documentation may be preferable ^[71].

If the buyer is in New York and wants this exact product, another IUL option is needed because Growth IUL II is unavailable there ^[72]. If the buyer prioritizes a simpler guaranteed-premium permanent policy over index-linked cash value, whole life or guaranteed universal life may fit better ^[72].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Ameritas Life Insurance Corp. before signing a Growth IUL II contract?
• Which illustration assumptions should a buyer stress-test before buying Ameritas Growth IUL II?

Ask Ameritas or the agent these questions before signing anything. The list consolidates verification items raised across platforms.

1. What are the current cap rates, participation rates, spreads, floors, index options, and guaranteed minimum crediting provisions in my state ^[73]?
2. What are the guaranteed and current cost-of-insurance, administrative, premium, rider, withdrawal, loan, and surrender charges by policy year ^[73]?
3. What exact premium amounts and timing are required to prevent lapse under guaranteed assumptions and under illustrated assumptions ^[73]?
4. Can premiums be skipped, reduced, increased, or front-loaded, and are there minimum premiums or maximum funding limits ^[73]?
5. Does the policy include a no-lapse guarantee, and what premium schedule and loan restrictions are required to preserve it ^[73]?
6. How do fixed and indexed loan options affect credited value, death benefit, lapse risk, and taxes ^[73]?
7. What are the guaranteed cash values and death benefits at ages 65, 75, 85, 95, and 100 under several lower-crediting scenarios ^[73]?
8. Which riders are available, what do they cost, and can they change the policy's lapse or funding requirements ^[73]?
9. Is Growth IUL II currently available in my state, and is the quoted illustration based on the exact contract form that would be issued ^[73]?
10. What is the surrender charge schedule by policy year, and are there exceptions for certain life events ^[77]?
11. Does the policy offer Option A (Level) and Option B (Increasing) death benefit choices, and what are the tax implications of each ^[77]?
12. How does the policy's net cost compare to functionally equivalent illustrations from Protective, John Hancock, Pacific Life, and Principal for the same premium and death benefit ^[77]?
13. Is the AM Best rating current as of the policy purchase date, and are there any rating outlook changes ^[77]?

Final AI Consensus Verdict

Ameritas Life Insurance Corp. is a good, but not conclusively best, fit for indexed universal life insurance with flexible premium options. The product family matches the use case, and the carrier has strong 2026 financial-strength evidence, including an AM Best A (Excellent) rating affirmed June 4, 2026 ^[78] and an S&P A+ stable rating dated April 8, 2026 ^[79].

The consensus breaks down on verifiability. Grok rated the fit strong based on third-party product guides ^[80]. OpenAI and Perplexity rated it good ^[81]. DeepSeek rated it mixed ^[83]. Kimi rated it uncertain ^[84]. No platform rated it poor.

Purchase consideration should depend on a state-specific illustration and contract review, not the historical 9.50% cap alone ^[85]. The available public information is insufficient to confirm that Growth IUL II offers the best combination of flexible premiums, policy charges, guaranteed protection, and lapse safeguards ^[81]. Buyers should obtain a personalized illustration, confirm in-force requirements, and compare against guaranteed universal life and term alternatives before purchasing ^[83].

How This Review Was Produced

This review aggregates fit assessments from five AI platforms that evaluated Ameritas Life Insurance Corp. for indexed universal life insurance with flexible premium options: OpenAI (gpt-5.6-luna), DeepSeek (deepseek-v4-flash), Grok (x-ai/grok-4.3), Perplexity (perplexity/sonar), and Kimi (moonshotai/kimi-k2.6). The study research date is 2026-09-20.

Two of the five platforms named Ameritas during the ranking stage, at an average listed rank of 7.5 and a best listed rank of 7. The ranking stage counts only platforms that named the entity during ranking discovery; all five platforms evaluated fit.

Platform fit ratings were: OpenAI good, Perplexity good, Grok strong, DeepSeek mixed, Kimi uncertain. This review preserves those ratings rather than averaging them into a single score.

Citations are platform-reported evidence, not independently verified facts. Company-owned sources are identified as owned; independent sources are identified as independent. Where a platform supplied no citation for a factual claim, the claim is labeled platform-reported or unverified.

Methodology Limitations

Several limitations apply to this review.

Platform-reported research dates differ from the authoritative run date. DeepSeek reported a research date of 2026-01-15, while the run research date is 2026-09-20. Platform-reported dates are provenance metadata and do not independently prove freshness.

DeepSeek's response was produced with search disabled (search_enabled: false), so its findings rely on model knowledge rather than retrieved sources. Its claims require explicit verification before being treated as current facts.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

Current product specifications and charges were not sufficiently available in the reviewed public sources ^[86]. The publicly cited 9.50% cap is dated January 2024 and may not represent September 2026 terms ^[87]. No verified public evidence established the exact premium-flexibility limits or policy-lapse protection requirements ^[86].

State availability, product naming, underwriting rules, riders, and contract provisions may vary and were not verified for a particular state or applicant ^[86]. Financial-strength ratings are opinions of insurer claims-paying ability, not guarantees of policy performance, cash value, or investment return ^[89].

The specific cost figures attributed to Growth IUL II — including the 7% premium charge, $7 monthly policy fee, and surrender charges declining to zero in year 11 — come from independent distributor documents cited by Grok and were not independently verified in this study ^[92].